Early treatment of frostbite with hyperbaric oxygen and pentoxifylline: a case report. | Canada Hyperbarics Skip to main content
Clinical Guideline Undersea & hyperbaric medicine : journal of the Undersea and Hyperbaric Medical Society, Inc 2019

Early treatment of frostbite with hyperbaric oxygen and pentoxifylline: a case report.

Robins M — Undersea & hyperbaric medicine : journal of the Undersea and Hyperbaric Medical Society, Inc, 2019

Tier 2, Indexed

Automatically imported from PubMed based on relevance criteria.

Summary

What Researchers Did

Researchers reported a case of a 17-year-old male with frostbite treated early with hyperbaric oxygen and pentoxifylline.

What They Found

The patient received 13 hyperbaric oxygen treatments and oral pentoxifylline, initiated approximately two hours after rewarming. After 12 months of follow-up, both feet recovered full sensation, and the patient experienced no tissue loss or functional impairment.

What This Means for Canadian Patients

This case suggests that early intervention with hyperbaric oxygen and pentoxifylline might help preserve tissue and function in frostbite patients. Canadian patients experiencing frostbite, especially after rewarming, could potentially benefit from prompt medical evaluation and consideration of such early treatments.

Canadian Relevance

This study has no direct Canadian connection.

Study Limitations

As a single case report, this study's findings cannot be generalized and lack a control group for comparison.

Was this summary helpful?

Study Details

Study Type Clinical Guideline
Category Neurological
Source Pubmed
PubMed ID 31509908
Year Published 2019
Journal Undersea & hyperbaric medicine : journal of the Undersea and Hyperbaric Medical Society, Inc
MeSH Terms Administration, Oral; Adolescent; Combined Modality Therapy; Foot; Frostbite; Humans; Hyperbaric Oxygenation; Male; Pentoxifylline; Rewarming; Time-to-Treatment; Toes; Vasodilator Agents

Cite This Study

Share
Discuss with a qualified healthcare professional. Then: Review Coverage Guide View Recognised Conditions

Disclaimer: This study summary is provided for informational and educational purposes only. It does not constitute medical advice. The information presented reflects the findings of the original research authors and may not represent the views of Canada Hyperbarics. Always consult a qualified healthcare professional before making treatment decisions.